Study to improve PrEP use in primary care
Part of Immune system & allergy, Infections clinical trials.
This trial tests ways to help primary care providers and their patients start using PrEP, a daily pill that prevents HIV. It may be right for you if you are interested in HIV prevention.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have a primary care appointment at a Henry Ford clinic during the study.
- You have an online health record account (MyChart).
- You are not already taking PrEP.
- You do not have HIV.
- Your doctor thinks you could benefit from PrEP.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial trains primary care providers at certain clinics to better offer PrEP, a daily pill that prevents HIV, to adolescents and young adults. If you are a provider at one of the listed clinics, you may be able to help improve how this prevention is delivered.
This study tests whether a counseling program helps healthcare providers better support patients who could benefit from PrEP (medicine that prevents HIV). It looks at how well providers identify and discuss PrEP with patients.
This study tests ways to help people stick with their PrEP (the medicine that prevents HIV). If you're getting PrEP through West Virginia Health Right and have a smartphone, you may be able to join.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
This study tests a new approach to help men at risk for HIV stay healthy by providing access to PrEP through a mobile app. The goal is to see if the program helps men start and stay on PrEP compared to standard care.
Hear when a new HIV Seropositivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.